⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10763379 | 1.00 | — | — | |
| SCHEMBL5794893 | 0.74 | — | — | |
| SCHEMBL13269108 | 0.74 | — | — | |
| SCHEMBL7292702 | 0.74 | — | — | |
| SCHEMBL7927894 | 0.70 | — | — | |
| SCHEMBL2954200 | 0.69 | — | — | |
| SCHEMBL9292 | 0.67 | — | — | |
| SCHEMBL8094788 | 0.67 | — | — | |
| SCHEMBL2945519 | 0.65 | — | — | |
| SCHEMBL898464 | 0.64 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1627 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024135721-A1 | METHOD FOR PRODUCING PRODUCTION INTERMEDIATE, PRODUCTION INTERMEDIATE THEREOF, AND METHOD FOR PRODUCING CROSSLINKED ARTIFICIAL NUCLEIC ACID INTERMEDIATE BY USING SAME | 田辺三菱製薬株式会社 | 2024-06-27 | — | — | WO | claimed |
| WO-2024120505-A1 | FUSED RING DERIVATIVE, PREPARATION METHOD THEREFOR, INTERMEDIATES THEREOF, AND USE THEREOF | 上海枢境生物科技有限公司 | 2024-06-13 | — | — | WO | claimed |
| WO-2024114531-A1 | HETEROCYCLIC COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 四川科伦博泰生物医药股份有限公司 | 2024-06-06 | — | — | WO | claimed |
| WO-2024114318-A1 | DRUG LINKER COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF | 四川科伦博泰生物医药股份有限公司 | 2024-06-06 | — | — | WO | claimed |
| CN-118125950-A | Chiral alpha-amino acid derivative and preparation method and application thereof | 四川大学 | 2024-06-04 | — | — | CN | claimed |
| CN-118105508-A | Medicinal linker compound, preparation method and application thereof | 四川科伦博泰生物医药股份有限公司 | 2024-05-31 | — | — | CN | claimed |
| WO-2024060356-A1 | ECONOMICAL AND FEASIBLE METHOD FOR INDUSTRIALLY PRODUCING DEUTERATED COVID-19 MEDICAMENT KEY INTERMEDIATE | 广州谷森制药有限公司 | 2024-03-28 | — | — | WO | claimed |
| CN-117247337-A | Method for asymmetrically synthesizing 1, 2-trans-amino alcohol and derivative thereof | 凯特立斯（深圳）科技有限公司 | 2023-12-19 | — | — | CN | claimed |
| CN-117143177-A | Preparation method of drug connector conjugate and intermediate thereof | 苏州宜联生物医药有限公司 | 2023-12-01 | — | — | CN | claimed |
| CN-117143178-A | Preparation method of drug connector conjugate and intermediate thereof | 苏州宜联生物医药有限公司 | 2023-12-01 | — | — | CN | claimed |
| US-5352687-A | Hypotensive agents | BAYER AKTIENGESELLSCHAFT (DE) | 1994-10-04 | — | — | US | claimed |
| WO-1993012659-A1 | AGRICULTURAL USE OF CERTAIN COMPOUNDS, COMPOSITIONS AND METHODS FOR PRODUCING SAID COMPOUNDS | NOVO NORDISK A/S (DK) | 1993-07-08 | — | — | WO | claimed |
| EP-0393457-A1 | Proteinase inhibitor | SUNTORY LIMITED (JP) | 1990-10-24 | — | — | EP | claimed |
| EP-0360760-A2 | Pipecolic acid containing cyclopeptolides, their preparation and pharmaceutical compositions containing them | SANDOZ AG (CH) | 1990-03-28 | — | — | EP | claimed |
| US-4841042-A | Process for the preparation of carbapenem intermediates | BAYER AKTIENGESELLSCHAFT (DE) | 1989-06-20 | — | — | US | claimed |
| US-4840946-A | Benzazolythio-carbapenem antibiotics | BAYER AKTIENGESELLSCHAFT (DE) | 1989-06-20 | — | — | US | claimed |
| US-4778790-A | HYPOTENSIVE AGENTS | SANKYO COMPANY LIMITED (JP) | 1988-10-18 | — | — | US | claimed |
| US-4767863-A | Isoxazoline intermediates | BRISTOL-MYERS COMPANY (US) | 1988-08-30 | — | — | US | claimed |
| EP-0268963-A1 | Benzazolylthio-carbapenem antibiotics | BAYER AG (DE) | 1988-06-01 | — | — | EP | claimed |
| EP-0195963-A1 | Process for the preparation of carbapenem intermediates | BAYER AG (DE) | 1986-10-01 | — | — | EP | claimed |